Pharmacologic considerations in the treatment of anxiety and depression in medical practice.

B. J. Goldstein, B. Brauzer

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)485-494
Number of pages10
JournalMedical Clinics of North America
Volume55
Issue number2
StatePublished - Mar 1 1971

Fingerprint

Drug Synergism
Tranquilizing Agents
Hypochondriasis
Urogenital System
Digestive System
Guilt
Autonomic Nervous System
Sleep Initiation and Maintenance Disorders
Amphetamine
Cardiovascular System
Hypnotics and Sedatives
Antidepressive Agents
Fear
Anxiety
Depression

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pharmacologic considerations in the treatment of anxiety and depression in medical practice. / Goldstein, B. J.; Brauzer, B.

In: Medical Clinics of North America, Vol. 55, No. 2, 01.03.1971, p. 485-494.

Research output: Contribution to journalArticle

@article{b21b1cb3962b4cb0b2248c7974d5944d,
title = "Pharmacologic considerations in the treatment of anxiety and depression in medical practice.",
author = "Goldstein, {B. J.} and B. Brauzer",
year = "1971",
month = "3",
day = "1",
language = "English",
volume = "55",
pages = "485--494",
journal = "Medical Clinics of North America",
issn = "0025-7125",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Pharmacologic considerations in the treatment of anxiety and depression in medical practice.

AU - Goldstein, B. J.

AU - Brauzer, B.

PY - 1971/3/1

Y1 - 1971/3/1

UR - http://www.scopus.com/inward/record.url?scp=0015026010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015026010&partnerID=8YFLogxK

M3 - Article

VL - 55

SP - 485

EP - 494

JO - Medical Clinics of North America

JF - Medical Clinics of North America

SN - 0025-7125

IS - 2

ER -